Friday, March 22, 2024 10:14:16 AM
-- Record net revenue for 2023 of $909.0 million compared to $712.2 million in 2022, an increase of 28%. Net revenue for the fourth quarter of 2023 was $248.5 million, compared to $240.4 million in the fourth quarter of 2022, an increase of 3%, with sequential growth in the Cannabis Retail and Cannabis Operations segments.
-- Gross profit grew to a record $190.4 million, or 21% of sales, for 2023, compared to $140.4 million, or 20% of sales, in the previous year, representing an increase of 36%. Record gross profit of $57.3 million, or 23% of sales, for the fourth quarter of 2023, compared to $43.6 million, or 18% of sales, in the fourth quarter of 2022. This improvement underscores the benefit of our supply chain optimization strategy, including the closure of the Olds, Alberta cultivation facility in October 2023.
-- Cash flow was negative $84.5 million in 2023, compared to negative $278.7 million, a 70% year-over-year improvement. In the fourth quarter of 2023, cash flow was negative $6.9 million, compared to negative $11.8 million in the fourth quarter of 2022, a 42% improvement. SNDL achieved positive cash flow in the second half of 2023, totaling $9.6 million.
-- Positive free cash flow1 achieved in the second half of 2023, totaling $17.7 million. This achievement was marked by positive free cash flow of $16.3 million in the third quarter of 2023 and $1.4 million in the fourth quarter of 2023, despite the working capital build up in anticipation of the holiday season in the latter quarter.
-- Operating income loss of $162.8 million for 2023, partly attributable to restructuring charges of $19.6 million and goodwill impairment of $29.0 million. This compares to a loss of $347.8 million in the previous year, marking a 53% improvement driven by revenue and margin expansion. Operating income loss of $84.9 million for the fourth quarter of 2023, including $13.3 million of restructuring cost and $29.0 million of goodwill impairment, compared to a loss of $154.6 million in the fourth quarter of 2022, a 45% improvement.
-- Adjusted EBITDA from continuing operations2 was $29.2 million in 2023, compared to an Adjusted EBITDA from continuing operations loss of $15.8 million in the previous year. Adjusted EBITDA from continuing operations was $3.5 million for the fourth quarter of 2023, compared to an Adjusted EBITDA from continuing operations loss of $7.5 million in the fourth quarter of 2022, a 147% improvement.
Recent SNDL News
- SunStream USA Poised to Acquire Cannabis Assets • PR Newswire (Canada) • 05/02/2024 11:00:00 AM
- SunStream USA Poised to Acquire Cannabis Assets • PR Newswire (US) • 05/02/2024 11:00:00 AM
- Cannabis Stocks On The Move Amid DEA Reclassification Indication • AllPennyStocks.com • 04/30/2024 08:59:00 PM
- SNDL to Announce First Quarter 2024 Financial Results on May 9, 2024 • PR Newswire (US) • 04/26/2024 11:00:00 AM
- SNDL to Announce First Quarter 2024 Financial Results on May 9, 2024 • PR Newswire (Canada) • 04/26/2024 11:00:00 AM
- SNDL to Participate in Upcoming International Cannabis Conferences • PR Newswire (US) • 04/09/2024 11:00:00 AM
- SNDL to Participate in Upcoming International Cannabis Conferences • PR Newswire (Canada) • 04/09/2024 11:00:00 AM
- SNDL and Nova Cannabis Announce Assignment of Dutch Love Stores to Nova Cannabis and Extension of Credit Facility • PR Newswire (US) • 04/01/2024 11:29:00 PM
- SNDL and Nova Cannabis Announce Assignment of Dutch Love Stores to Nova Cannabis and Extension of Credit Facility • PR Newswire (Canada) • 04/01/2024 11:29:00 PM
- SNDL and Nova Cannabis Announce Assignment of Dutch Love Stores to Nova Cannabis and Extension of Credit Facility • PR Newswire (Canada) • 04/01/2024 11:29:00 PM
- U.S. Index Futures Rise as Fed’s Dovish Outlook Spurs Positive Investor Sentiment; Oil Prices See Minor Declines • IH Market News • 03/21/2024 11:26:38 AM
- SNDL Reports Full Year and Fourth Quarter 2023 Financial and Operational Results • PR Newswire (Canada) • 03/21/2024 09:58:00 AM
- SNDL Reports Full Year and Fourth Quarter 2023 Financial and Operational Results • PR Newswire (US) • 03/21/2024 09:58:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/01/2024 04:48:56 PM
- SNDL to Announce Year End and Fourth Quarter 2023 Financial Results on March 21, 2024 • PR Newswire (Canada) • 03/01/2024 12:00:00 PM
- SNDL to Announce Year End and Fourth Quarter 2023 Financial Results on March 21, 2024 • PR Newswire (US) • 03/01/2024 12:00:00 PM
- SNDL and Nova Cannabis Remain Committed to Partnership Following the Termination of the Implementation Agreement • PR Newswire (US) • 11/17/2023 11:47:00 PM
- SNDL and Nova Cannabis Remain Committed to Partnership Following the Termination of the Implementation Agreement • PR Newswire (Canada) • 11/17/2023 11:47:00 PM
- SNDL and Nova Cannabis Remain Committed to Partnership Following the Termination of the Implementation Agreement • PR Newswire (Canada) • 11/17/2023 11:45:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2023 03:43:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2023 03:41:09 PM
- SNDL Announces Renewal of Share Repurchase Program • PR Newswire (Canada) • 11/13/2023 12:05:00 PM
- SNDL Announces Renewal of Share Repurchase Program • PR Newswire (US) • 11/13/2023 12:05:00 PM
- SNDL Reports Third Quarter 2023 Financial and Operational Results and Achieves Positive Net Cash from Operating Activities and Free Cash Flow • PR Newswire (US) • 11/13/2023 12:00:00 PM
- SNDL Reports Third Quarter 2023 Financial and Operational Results and Achieves Positive Net Cash from Operating Activities and Free Cash Flow • PR Newswire (Canada) • 11/13/2023 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM